MUMBAI, India, Aug. 17 -- Intellectual Property India has published a patent application (202617084266 A) filed by Catavax Inc on July 09, 2026, for Cancer Vaccine Based On Mhc-Ii Epitope Selection.
Inventors include Nielsen, Morten; Holst, Peter, Johannes; and Nrgaard, Anders, Kaare.
The application for the patent was published on August 14, 2026, under issue no. 33/2026.
Abstract: The present disclosure provides a vaccine against cancers that express MHC-II. That includes hormone positive breast cancers and some prostate cancers and melanoma. It is possible, based on a genomic test of the individual, to either (1) design a personal vaccine consisting of a polytope based on epitopes from the TAA that in most cases display on MHC-II and ...